Kelli Bramlett is the Executive Director of Molecular Oncology at Quest Diagnostics since 2023. Previously, Kelli held various roles, including Drug Discovery Research at Eli Lilly and Company from 2000 to 2007, and Research Associate at UT MD Anderson Cancer Center from 1997 to 2000. Kelli also served as Director of R&D at Thermo Fisher Scientific from 2016 to 2023, managing a team to develop innovative oncology products. Kelli earned a Master's degree in Pharmacology from Indiana University School of Medicine and a Bachelor's degree in Chemistry from Rice University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices